Navigation Links
STAAR Surgical to Present at the Noble Financial Equity Conference
Date:8/11/2008

MONROVIA, Calif., Aug. 11 /PRNewswire-FirstCall/ -- STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, announced today that it will present at the at the upcoming Fourth Annual Noble Financial Equity Conference which will be held Monday, August 18th - Tuesday, August 19th, 2008 at the Loews Lake Las Vegas Resort, Nevada. Barry G. Caldwell, President and Chief Executive Officer will discuss the Company's business strategy and historical financial performance at 11:00 a.m. Pacific Time on Monday, August 18th.

A live audio webcast of STAAR Surgical's presentation may be accessed through the Company's website at http://www.staar.com. The presentation will feature high-definition, streaming video and PowerPoint slides. It is recommended that interested parties register 15 minutes prior to the start of the presentation to ensure timely access. An archived replay of the presentation will be available after the live presentation, and can also be accessed at http://www.staar.com.

About STAAR Surgical

STAAR Surgical is a leader in the development, manufacture and marketing of minimally invasive ophthalmic products employing proprietary technologies. STAAR's products are used by ophthalmic surgeons and include the Visian ICL, a tiny, flexible lens implanted to correct refractive errors, as well as innovative products designed to improve patient outcomes for cataracts and glaucoma. Manufactured in Switzerland by STAAR, the ICL is approved by the FDA for use in treating myopia, has received CE Marking and is sold in more than 40 countries. Collamer(R) is the brand name for STAAR's proprietary collagen copolymer lens material. More information is available at http://www.staar.com.

CONTACT: Investors Media

EVC Group EVC Group

Dahlia Bailey, 415-896-5862 Steve DiMattia 646-201-5445


'/>"/>
SOURCE STAAR Surgical Company
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. STAAR Surgicals Collamer(R) IOL and Elastimide(R) IOL Each Recognized with New Technology Intraocular Lens Classification
2. STAAR Surgicals LASIK Alternative Expands U.S. Market Gains
3. STAAR Surgical Reports Solid First Quarter Progress
4. STAAR Surgical Announces First Quarter 2008 Earnings Release Date and Conference Call
5. STAAR Surgical Plans Major Presence at ASCRS
6. STAAR Surgical Reports Fourth Quarter and Year End Results
7. STAAR Surgicals Visian ICL Procedure Performed Live on NBCs Today show
8. STAAR Surgical Announces Fourth Quarter and Full Year 2007 Earnings Release Date and Conference Call
9. STAAR Surgical to Present at the Tenth Annual Needham Growth Conference
10. STAAR Surgical Completes $5M Debt Financing for Purchase of Japanese Joint Venture
11. STAAR Surgical to Present at the BMO Capital Markets Focus on Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... February 08, 2016 , ... Steve Helwig & Associates ... vital new community enrichment program, has teamed up with Citizens Opposed to Domestic Abuse ... from intimate abuse. To support all those victimized by the fear of violence in ...
(Date:2/8/2016)... , ... February 08, 2016 , ... Delta Dental of ... help combat pancreatic cancer. , Gary D. Radine, who recently retired as president and ... American Cancer Society’s 2015 CEO of the Year , helped lead the effort ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... While a significant number of women and men with eating disorders report a ... that best predicts the development of an eating disorder. , At the ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... than 50% lower incidence rate of type 2 diabetes in the GrassrootsHealth cohort ... is time to make a change in public health,” states Carole Baggerly, Director ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... speaking on how healthcare companies can use newly released government data on populations ... a population and intervene and capture the value they create to succeed in ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... -- A research team led by St. Jude Children,s ... the abnormal breakage and rearrangement of chromosomes in white ... lymphoblastic leukemia (ALL). Such leukemias are cancers of white ... immature cells, called lymphoblasts. --> ... the type called "Ph-like ALL" will aid in designing ...
(Date:2/8/2016)... PALO ALTO, Calif. , Feb. 8, 2016 ... chemical manufacturing, and Kodiak Sciences Inc., a biopharmaceutical company ... retinal disease, announced today agreements for the clinical supply ... manufacture material at multiple sites, including Slough (UK), Visp ... --> Retinal diseases, such as age-related ...
(Date:2/8/2016)... 2016  The University of Michigan Health System in ... as part of the development of four new operating ... in the U.S. to start using new top-of-the-line neurosurgical ... chair of neurosurgery. --> Karin Muraszko ... The BrightMatter technology from Synaptive Medical – a ...
Breaking Medicine Technology: